久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Bird Rock Bio Files IND for Study of Nimacimab for Renal Diseases americanpharmaceuticalreview
    June 05, 2020
    Bird Rock Bio announced the Company has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a phase 2 clinical study of nimacimab, also known as RYI-018 ...
PharmaSources Customer Service